The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. Retrospective analysis of their medical records revealed that a mean ag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Conchon, Monika, Sanabani, Sabri S., Bendit, Israel, Dinardo, Carla Luana, Dias, Lucia, Chamone, Dalton de Alencar Fischer, Dorlhiac-Llacer, Pedro Enrique, Dulley, Frederico Luiz
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://ncbi.nlm.nih.gov/pubmed/20107580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/357093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados